Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype
Journal of Alzheimer's Disease · 2023
DOI: 10.3233/jad-220869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Jian-Guo Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Center at Temple, Lewis Katz School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
The endosomal retromer complex system is a key controller for trafficking of proteins. Downregulation of its recognition core proteins, such as VPS35, is present in Alzheimer’s disease (AD) brain, whereas its normalization prevents the development of AD pathology in a transgenic model with amyloid-β deposits and tau tangles.
Objective
Assess the effect of targeting VPS35 after the AD pathology and memory impairments have developed.
Methods
Twelve-month-old triple transgenic mice were treated with a small pharmacological chaperone, TPT-172, or vehicle for 14 weeks. At the end of this period, the effect of the drug on their phenotype was evaluated.
Results
While control mice had a decline of learning and memory, the group receiving the chaperone did not. Moreover, when compared with controls the treated mice had significantly less amyloid-β peptides and phosphorylated tau, elevation of post-synaptic protein, and reduction in astrocytes activation.
Conclusion
Taken together, our findings demonstrate that pharmacologic stabilization of the retromer recognition core is beneficial also after the AD-like pathologic phenotype is established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Alzheimer's Center at Temple, Lewis Katz School of Medicine, Philadelphia, PA, USA.
- Moulder Center for Drug Discovery Research, School of Pharmacy, Temple University, Philadelphia, PA, USA.
Zitieren
APA
Li, J. G., Blass, B. E., & Praticò, D. (2023). Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-220869
Vancouver
Li JG, Blass BE, Praticò D. Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-220869
BibTeX
@article{Li2023,
author = {Li, Jian-Guo and Blass, Benjamin E and Praticò, Domenico},
title = {Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer’s Disease Phenotype},
journal = {Journal of Alzheimer's Disease},
year = {2023},
doi = {10.3233/jad-220869}
}
EUVIMED